Heliyon is a monthly peer-reviewed open-access mega journal covering research in science, medicine and engineering. Unlike most of its competitors, the journal will consider for publication works reporting negative/null results, incremental advances, and replication studies, thus filling the market niche, which became vacant after the discontinuation of the Journal of Negative Results in Biomedicine in 2017.
6-498: Heliyon was established in 2015 by Cell Press , a division of Elsevier . According to the publisher's website: "the [journal's] name is all about shining light on important research. Helios was the Greek god of the sun. This root word gave us inspiration, as we want this journal to illuminate knowledge across a broad spectrum." The journal is divided into numerous sections, each with its own editorial team . Articles are published under
12-525: A CC BY open access license. The journal is abstracted and indexed in: As of October 2024, the journal's indexation in the Science Citation Index Expanded is "on hold" and pending re-evaluation, with Web of Science citing the concerns on "the quality of the content published in this journal" as a reason for the suspension. Cell Press Cell Press is an all-science publisher of over 50 scientific journals across
18-1057: The journal joined Cell Press. Cell Chemical Biology (formerly titled Chemistry & Biology ) launched on April 15, 1994, and joined Cell Press in January 2002. In 2007, Cell Press acquired the Trends family of journals, 16 review journals covering the life, physical, and medical sciences. In October 1995, Cell.com was launched and full-text online versions were launched in July 1997. Cell Press published its first open access journal, Cell Reports , in 2012. In January 2021, all Cell Press journals began offering open access publishing options. As of May 2022, Cell Press publishes 17 open access journals and 40 hybrid journals. In 2021, 50% of all articles published in Cell Press were open access. In 2016 Cell Press launched STAR Methods . STAR (Structured Transparent Accessible Reporting) Methods
24-1002: The life, physical, earth, and health sciences, both independently and in partnership with scientific societies. Cell Press was founded and is currently based in Cambridge , MA , and has offices across the United States , Europe , and Asia under its parent company Elsevier . Benjamin Lewin founded Cell . He then bought the title and established an independent Cell Press in 1986. The company spun off new journals as follows: Neuron in March 1988; Immunity in April 1994; and Molecular Cell in December 1997. Benjamin Lewin left in October 1999, after having sold Cell Press to Elsevier
30-561: The previous April. Since that time, Cell Press has launched a number of new titles: Developmental Cell in July 2001; Cancer Cell in February 2002; Cell Metabolism in January 2005; Cell Host & Microbe in March 2007; Cell Stem Cell in July 2007; Cell Systems in July 2015; Heliyon 2015; Chem in July 2016; Joule in September 2017; iScience in March 2018; and One Earth in September 2019. Cell Genomics
36-426: Was added in 2021. Meanwhile, three additional Elsevier journals have joined the Cell Press group: Current Biology launched in January 1996, which became part of Cell Press in early 2001; Structure launched in 1993, which merged with the journal Folding & Design in early 1999. At that point, the name changed to Structure with Folding & Design but reverted to Structure at the beginning of 2001, when
#602397